Canaan's Lee on VC fundraising, evolution of LP demands - The Deal Pipeline (SAMPLE CONTENT: NEED AN ID?)
Subscriber Content Preview | Request a free trialSearch  
  Go

Video

Share  |  Reprint

Canaan's Lee on VC fundraising, evolution of LP demands

Published March 5, 2012 at 4:00 AM

Clear, aligned incentives is what limited partners want to see when investing money in a venture capital firm, says Warren Lee of Canaan Partners. Lee tells The Deal Pipeline about the impact of anemic VC fundraising on LPs. - Sarah Hashim-Waris
Share:

Meet the journalists



Movers & Shakers

Launch Movers and shakers slideshow

Three directors are leaving Valeant Pharmaceuticals International's board, including Warburg Pincus' Fred Hassan, ValueAct's G. Mason Morfit and Persistence Capital's Lloyd M. Segal. For other updates launch today's Movers & shakers slideshow.

Video

Ackman goes raider route in backing Valeant's Allergan bid

The move suggests activism has entered a new phase. But as seen with the Men′s Wearhouse-Jos. A. Bank merger, it′s just another way for dissident investors to push their agendas. More video

Sectors